Missouri Cancer Associates Revenue and Competitors
Estimated Revenue & Valuation
- Missouri Cancer Associates's estimated annual revenue is currently $17.5M per year.
- Missouri Cancer Associates's estimated revenue per employee is $243,000
Employee Data
- Missouri Cancer Associates has 72 Employees.
- Missouri Cancer Associates grew their employee count by 9% last year.
Missouri Cancer Associates's People
Name | Title | Email/Phone |
---|---|---|
1 | Nurse Practitioner | Reveal Email/Phone |
Missouri Cancer Associates Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.3M | 43 | 54% | N/A | N/A |
#2 | $520.1M | 1376 | 4% | N/A | N/A |
#3 | $8.9M | 41 | -5% | N/A | N/A |
#4 | $9.5M | 44 | 10% | N/A | N/A |
#5 | $21.9M | 81 | 7% | N/A | N/A |
#6 | $4M | 21 | -52% | N/A | N/A |
#7 | $36.5M | 135 | 2% | N/A | N/A |
#8 | $13.1M | 54 | 13% | N/A | N/A |
#9 | $7.6M | 35 | 9% | N/A | N/A |
#10 | $25.1M | 93 | 6% | N/A | N/A |
What Is Missouri Cancer Associates?
Missouri Cancer Associates has been providing standardized, state-of-the-art cancer treatment in Missouri for over 36 years. Patient-centered care is at the root of what we do. Additionally, the services our treatment center offers on-site allows most patients to receive chemotherapy and radiation on the same day they see their medical oncologist. Missouri Cancer Associates offers a on-site pharmacy and lab. Through state of the art medical technology, highly experienced physicians and quality patient care, Missouri Cancer Associates has become the Premier Cancer Treatment Center in Mid-Missouri.
keywords:N/AN/A
Total Funding
72
Number of Employees
$17.5M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $18.8M | 72 | 4% | N/A |
#2 | $7.5M | 72 | 6% | N/A |
#3 | $9.4M | 72 | 9% | N/A |
#4 | $13.6M | 72 | -9% | N/A |
#5 | $9.4M | 72 | 31% | N/A |